Some studies found that there was a significant association between asthma and the risk of lung cancer. However, the results are inconclusive. Therefore, we performed a meta-analysis. We searched the electronic databases for all relevant articles. Odds ratio (OR) with 95% confidence interval (CI) were used to calculate the strength of the association between asthma and lung cancer risk. Asthma was significantly associated with the increased risk of lung cancer (OR = 1.44; 95% CI 1.31-1.59; P < 0.00001; I 2 = 83%). Additionally, asthma patients without smoking also had the increased lung cancer risk. In the subgroup analysis of race and gender, Caucasians, Asians, male, and female patients with asthma showed the increased risk of lung cancer. However, asthma was not significantly associated with lung adenocarcinoma risk. In the stratified analysis by asthma definition, significant associations were found between asthma and lung cancer in self-reported subgroup, questionnaire subgroup, and register databases subgroup. However, no significant association was observed in physician-diagnosed asthma subgroup. In conclusion, this meta-analysis suggested that asthma might be significantly associated with lung cancer risk.
INTRODUCTION
Lung cancer is one of the most common malignant tumors affecting millions of people around the world. It is acknowledged that smoking is the most important risk factor of lung cancer [1] . Sun et al. suggested that approximately 25% of lung cancer cases worldwide are not attributable to tobacco use [2] . This fact indicated that other factors might contribute to susceptibility to lung cancer.
Asthma is one of the most common diseases of childhood, with an estimated global prevalence of 10% among children aged 6-7 [3] . It is a condition characterized by chronic inflammation of the lungs, presenting with airway hyper-reactivity, excessive mucous formation, and respiratory obstruction. The chronic inflammation had an important role in the cancer development [4] . Thus, the chronic inflammation in conditions such as asthma might lead to lung cancer development. Some studies found that there was a significant association between asthma and the risk of lung cancer. However, the results are inconclusive [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . Therefore, we performed a meta-analysis to determine the association between asthma and lung cancer risk.
RESULTS

Characteristics of eligible studies
The detailed literature search strategy was showed in Figure 1 . A total of 884 potential studies were identified by preliminary searching. After carefully review, 18 studies were included in this meta-analysis [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . Four studies reported two independent studies. Thus, 22 studies with 16375202 subjects were included. 
Association of asthma and risk of lung cancer
As shown in Figure 2 , asthma was significantly associated with the increased risk of lung cancer (odds ratio (OR) = 1.44; 95% confidence interval (CI) 1.31-1.59; P < 0.00001; I 2 = 83%). Additionally, asthma patients without smoking also had the increased lung cancer risk (OR = 1.28; 95% CI 1.10-1.50; P = 0.002; I 2 = 0%). In the subgroup analysis of race, both Caucasians and Asians with asthma showed the same results (OR = 1.53; 95% CI 1.37-1.72; P < 0.00001; I 2 = 56%; OR = 1.52; 95% CI 1.15-2.01; P < 0.00001; I 2 = 93%). In the stratified analysis by gender, both male and female patients with asthma showed the increased risk of lung cancer (OR = 1.38; 95% CI 1.31-1.46; P < 0.00001; I 2 = 24%; OR = 1.68; 95% CI 1.45-1.95; P < 0.00001; I 2 = 63%). However, asthma was not significantly associated with lung adenocarcinoma risk (OR = 1.01; 95% CI 0.69-1.50; P = 0.95; I 2 = 45%). In the stratified analysis by asthma definition, significant associations were found between asthma and lung cancer in self-reported subgroup (OR = 1.23; 95% CI 1.03-1.48; P = 0.02; I 2 = 53%), questionnaire subgroup (OR = 1.32; 95% CI 1.12-1.57; P = 0.001; I 2 = 0%), and register databases subgroup (OR = 1.60; 95% CI 1.42-1.79; P < 0.00001; I 2 = 91%). However, no significant association was observed in physician-diagnosed asthma subgroup (OR = 1.26; 95% CI 0.96-1.65; P = 0.10; I 2 = 0%). The results were showed in Table 2 .
In the sensitive analysis, similar data were observed after sequentially excluding each study (Figure 3 ). Furthermore, when the studies without adjustment were excluded, the result was still statistically significant (OR = 1.43, 95% CI 1.28-1.60, P < 0.00001; I 2 = 80%). In addition, after excluding the studies without adjusting Huang smoking and age, the result was not changed (OR = 1.29, 95% CI 1.12-1.48, P = 0.0004; I 2 = 27%). The results were showed in Table 3 .
The publication bias of the included studies was assessed by the funnel plot and Egger's test. The funnel plot was symmetric (Figure 4 ). Egger's test showed no significant publication bias (P = 0.683).
DISCUSSION
This present meta-analysis investigating the relationship between asthma and lung cancer risk.
Eighteen studies with a total of 16375202 individuals were included in this meta-analysis. Prior asthma was significantly associated with lung cancer risk. In the subgroup analysis of race, both Caucasians and Asians with asthma showed the same results. In the stratified analysis by gender, both male and female patients with asthma showed the increased risk of lung cancer. Smoke habit was a recognized risk factor for lung cancer. However, asthma patients without smoking also had the increased lung cancer risk. These results suggested that asthma might be an independent risk factor for lung cancer. Lung cancer is classified small cell lung cancer and adenocarcinoma, squamous cell carcinoma, and large cell carcinoma [23] . Asthma was not significantly associated with lung adenocarcinoma risk in this metaanalysis. Future studies should be performed to assess the association between asthma and other pathological types of lung cancer. In the stratified analysis by asthma definition, significant associations were found in selfreported subgroup, questionnaire subgroup, and register databases subgroup. However, no significant association was observed in physician-diagnosed asthma subgroup.
Only four studies were included in this subgroup. A positive association could therefore not be ruled out, because studies with small sample sizes may have had insufficient statistical power to detect any slight effect.
To determine the stability of the result, we did sensitivity analysis. Removal of each study did not change the result, suggesting the reliability of our result. The adjusted ORs could be used to overcome some of the confounding within the observational studies. Thus, we did sensitivity analysis by excluding the studies without adjustment. The result was still statistically significant. Asthma is a disease of chronic airway inflammation characterized by recurrent episodes of wheezing, dyspnea, chest tightness, and cough. Inflammatory cell types, such as T and B lymphocytes, mast cells, eosinophils, basophils, neutrophils and dendritic cells, as well as structural cell types including epithelial and mesenchymal cells involved in airway inflammation [24] . Inflammation also plays a pivotal role in the pathogenesis of lung cancer. Ballaz and Mulshine indicated that chronic inflammation contributes to the process of lung carcinogenesis [25] . Azad et al. suggested that chronic inflammation-induced production of reactive oxygen/nitrogen species in the lung may predispose individuals to lung cancer [26] .
This meta-analysis was stable and reliable. First, sensitivity analyses revealed that the results were robust. Second, no significant publication bias was found in this meta-analysis. Third, the sample size of this meta-analysis was large enough. Several limitations should be noted. First, other races, such as African, were not included. Second, heterogeneity was high in this meta-analysis. Third, subgroup analysis based on study level variables could be due to the potential for ecological fallacy. Therefore, more studies are required to confirm the results of this meta-analysis.
In conclusion, this meta-analysis suggested that asthma might be significantly associated with lung cancer risk.
MATERIALS AND METHODS
Publication search
Two authors (YLQ and JL) searched Pubmed, Embase, Chinese National Knowledge Infrastructure (CNKI) and Wanfang databases (www.wanfangdata. com.cn). We also checked American Society of Clinical Oncology (ASCO) meeting abstracts to find grey literature (http://meetinglibrary.asco.org/abstracts). Last search was updated in 10 Nov, 2016. We searched the bibliographies of identified studies and narrative reviews for additional citations. No language and time restriction were imposed in this meta-analysis. The detailed search strategy is showed in the Supplementary Material.
Study selection
Two authors (YLQ and JL) searched the titles and abstracts obtained from the initial electronic search for potentially relevant studies for full review. Two authors (YLQ and LXZ) then assessed the full text of the retrieved studies to determine whether the study met the inclusion criteria. Studies included in this meta-analysis should meet the following criteria: (1) study design: prospective cohort study, cross-sectional study, and longitudinal study; (2) population: individuals without lung cancer; (3) exposure: asthma or wheeze; (4) comparison: individuals without asthma or wheeze; (5) outcome: relative risk (RR), hazard ratio (HR), or OR with corresponding 95% CI of lung cancer risk in overall population and in non-smokers. If serial studies of the same population from the same group were reported, the largest study was included. Reviews, meta-analyses, letters, and editorial articles were all excluded. We resolved disagreement by consensus.
Data extraction and qualitative assessment
Two investigators (YLQ and JL) extracted the data independently. The following data were collected from each study: first author's name, year of publication, ethnicity, gender, age, asthma definition, lung cancer definition, duration of follow-up, sample size, and adjustment. The Newcastle-Ottawa Scale (NOS) was used to assess the quality of included studies.
Statistical analysis
ORs with 95% CIs were used to calculate the strength of the association between asthma and lung cancer risk. Random effects model was used in this meta-analysis. Heterogeneity among studies was examined with I 2 statistic and Q statistic. Subgroup analysis was carried out by smoke status, ethnicity, gender, subtype of lung cancer, and definition of asthma. Relative influence of each study on the pooled estimate was assessed by omitting one study at a time for sensitivity analysis. Sensitivity analysis was also performed by excluding studies without adjustment, studies without adjustment of age and smoking. Funnel plot and Begg's test were employed to evaluate publication bias. All statistical tests were performed using the STATA 11.0 software (Stata Corporation, College Station, TX). A P value < 0.05 was considered statistically significant, except for tests of heterogeneity where a level of 0.10 was used. All tests were two-sided.
